About Plex Pharmaceuticals
Plex Pharmaceuticals is a company based in San Diego (United States) founded in 2009 was acquired by Collidion in August 2017.. Plex Pharmaceuticals offers products and services including Neurodegenerative Drug Programs, Cataracts Treatment Molecules, and CNS Tumors Inhibitors. Plex Pharmaceuticals operates in a competitive market with competitors including Biogen, Denali Therapeutics, Annexon, Entrada Therapeutics and Adamas Pharma, among others.
- Headquarter San Diego, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Plex Pharmaceuticals, Incorporated
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Plex Pharmaceuticals
Plex Pharmaceuticals offers a comprehensive portfolio of products and services, including Neurodegenerative Drug Programs, Cataracts Treatment Molecules, and CNS Tumors Inhibitors. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Modulators for heat shock proteins to treat Parkinson's and ALS diseases.
Compounds that enhance alpha-crystallin activity to prevent cataract formation.
Inhibitors of HSP90 and TRAP-1 for treating glioblastoma and brain tumors.
Unlock access to complete
Unlock access to complete
Leadership Team
1 people
Sales and Marketing
1 people
Finance and Accounting
1 people
Scientific Team
1 people
Unlock access to complete
Funding Insights of Plex Pharmaceuticals
- Total Funding Total Funding
- Total Rounds 10
- Last Round Grant — $298,590
-
First Round
First Round
(05 Apr 2010)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2020 | Amount | Grant - Plex Pharmaceuticals | Valuation |
investors |
|
| Feb, 2020 | Amount | Grant - Plex Pharmaceuticals | Valuation |
investors |
|
| Feb, 2020 | Amount | Grant - Plex Pharmaceuticals | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Plex Pharmaceuticals
Plex Pharmaceuticals has secured backing from 5 investors, including institutional investors. Prominent investors backing the company include HHS, The Michael J. Fox Foundation and Collidion. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Vision research is conducted to eliminate vision loss.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Plex Pharmaceuticals
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Plex Pharmaceuticals
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Plex Pharmaceuticals Comparisons
Competitors of Plex Pharmaceuticals
Plex Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Biogen, Denali Therapeutics, Annexon, Entrada Therapeutics and Adamas Pharma, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapies for neurodegenerative and immunology disorders are developed.
|
|
| domain | founded_year | HQ Location |
Neurodegenerative disease therapies are developed for Alzheimer's, ALS, and Parkinson's.
|
|
| domain | founded_year | HQ Location |
Developer of antibodies to treat complement-mediated neurodegenerative diseases
|
|
| domain | founded_year | HQ Location |
Biologics platform developed for intracellular delivery in rare diseases.
|
|
| domain | founded_year | HQ Location |
Pharmacokinetic profiles of approved drugs are enhanced for CNS therapeutics.
|
|
| domain | founded_year | HQ Location |
T-cell-based therapies for autoimmune and degenerative diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Plex Pharmaceuticals
Frequently Asked Questions about Plex Pharmaceuticals
When was Plex Pharmaceuticals founded?
Plex Pharmaceuticals was founded in 2009 and raised its 1st funding round 1 year after it was founded.
Where is Plex Pharmaceuticals located?
Plex Pharmaceuticals is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
What does Plex Pharmaceuticals do?
Plex Pharmaceuticals (formerly CalAsia Pharmaceuticals), an early stage biotechnology company is focussed on discovering small molecules for diseases caused by protein misfolding such as Amyotrophic lateral sclerosis (ALS), Parkinsons disease. Its technology platform combines functional fragment screening with X-ray crystallography co-crystallization guided by structure-based design approach to design and synthesize New Chemical Entities (NCEs) with drug-like properties. Its discovery programs include modulators of heat shock proteins (Hsp) and FK506 Binding Protein (FKBP) for the treatment of Parkinsons disease (PD) and Amyotrophic lateral sclerosis (ALS); small molecule for the treatment of Glioblastoma multiforme. The company also has discovery and preclinical programs for Zika, Dengue, and West nile virus.
Who are the top competitors of Plex Pharmaceuticals?
Plex Pharmaceuticals's top competitors include Alector, Entrada Therapeutics and Annexon.
What products or services does Plex Pharmaceuticals offer?
Plex Pharmaceuticals offers Neurodegenerative Drug Programs, Cataracts Treatment Molecules, and CNS Tumors Inhibitors.
Who are Plex Pharmaceuticals's investors?
Plex Pharmaceuticals has 5 investors. Key investors include HHS, The Michael J. Fox Foundation, Collidion, NIAID, and National Eye Institute.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.